IOL Chemicals & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 574.41 | 559.06 | 532.30 |
| Operating Expense | 510.43 | 489.54 | 464.84 |
| Net Profit | 30 | 33.96 | 31.62 |
| Net Profit Margin | 5.22 | 6.07 | 5.94 |
| Earning Per Share | 1.02 | 1.16 | 5.38 |
| EBIDTA | 62.42 | 68.43 | 61.24 |
| Effective Tax Rate | 14.00 | 15.09 | 10.47 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 574.41 |
| Operating Expense | 510.43 |
| Net Profit | 30.00 |
| Net Profit Margin | 5.22 |
| Earning Per Share | 1.02 |
| EBIDTA | 62.42 |
| Effective Tax Rate | 14.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 2,079.21 | 2,132.79 | 2,217.11 |
| Operating Expenses Annual | 1,877.04 | 1,901.27 | 1,990.59 |
| Operating Profit Annual | 224.57 | 261.59 | 252.09 |
| Interest Annual | 14.76 | 16.10 | 16.47 |
| Depreciation | 71.92 | 62.85 | 46.13 |
| Net Profit Annual | 101 | 135.42 | 139.98 |
| Tax Annual | 36.89 | 47.22 | 49.51 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 2,079.21 |
| Operating Expenses Annual | 1,877.04 |
| Operating Profit Annual | 224.57 |
| Interest Annual | 14.76 |
| Depreciation | 71.92 |
| Net Profit Annual | 101 |
| Tax Annual | 36.89 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 7.53 | 0.96 | 1.12 |
| Cash Flow from Operations | 178.68 | 290.46 | 123.14 |
| Cash Flow from Investing | -154.23 | -191.39 | -119.19 |
| Cash Flow from Financing | 46.04 | -92.50 | -4.11 |
| Cash Flow at the End | 78.02 | 7.53 | 0.96 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 7.53 |
| Cash Flow from Operations | 178.68 |
| Cash Flow from Investing | -154.23 |
| Cash Flow from Financing | 46.04 |
| Cash Flow at the End | 78.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 10.80 | 12.27 | 11.37 |
| PBIT Margin (%) | 7.34 | 9.32 | 9.29 |
| PBT Margin (%) | 6.84 | 8.74 | 8.73 |
| Net PROFIT Margin (%) | 4.86 | 6.35 | 6.31 |
| Return On Networth / Equity (%) | 6.12 | 8.69 | 9.66 |
| Return On Networth /Employed (%) | 8.82 | 12.27 | 13.61 |
| Return On Assets (%) | 5.83 | 8.38 | 9.28 |
| Total Debt / Equity (X) | 0.05 | 0.04 | 0.04 |
| Asset Turnover Ratio (%) | 1.20 | 1.32 | 1.47 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 10.80 |
| PBIT Margin (%) | 7.34 |
| PBT Margin (%) | 6.84 |
| Net PROFIT Margin (%) | 4.86 |
| Return On Networth / Equity (%) | 6.12 |
| Return On Networth /Employed (%) | 8.82 |
| Return On Assets (%) | 5.83 |
| Total Debt / Equity (X) | 0.05 |
| Asset Turnover Ratio (%) | 1.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,171.46 | 933.73 | 759.55 |
| Total Current Assets Annual | 1,151.12 | 1,119.48 | 919.07 |
| Non Current Assets Annual | 1,230.66 | 1,124.49 | 1,101.54 |
| Total Shareholders Funds Annual | 1,687.41 | 1,611.33 | 1,506.55 |
| Total Assets Annual | 2,381.78 | 2,243.97 | 2,020.61 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,171.46 |
| Total Current Assets Annual | 1,151.12 |
| Non Current Assets Annual | 1,230.66 |
| Total Shareholders Funds Annual | 1,687.41 |
| Total Assets Annual | 2,381.78 |
EPS (INR)
Expected
1.02
Reported
1.02
Surprise
0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
